These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1193661)

  • 21. [Use of stabilized human cell lines derived from hematopoietic cells as models for testing cytostatics].
    Koubek K; Bumbrlová R; Bartos F; Chudomel V; Stöckbauer P; Procházková J
    Cesk Farm; 1984 Jul; 33(6):238-43. PubMed ID: 6498958
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical application of chemosensitivity testing using radioactive precursors].
    Ichihashi H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1156-62. PubMed ID: 3729437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
    Lyu MA; Kurzrock R; Rosenblum MG
    Biochem Pharmacol; 2008 Feb; 75(4):836-46. PubMed ID: 18082672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.
    Dou QP; Smith DM; Daniel KG; Kazi A
    Prog Cell Cycle Res; 2003; 5():441-6. PubMed ID: 14593738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin.
    Raaphorst GP; Mao J; Yang H; Goel R; Niknafs B; Shirazi FH; Yazdi HM; Rippstein P; Ng CE
    Anticancer Res; 1998; 18(4C):2945-51. PubMed ID: 9713489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
    Fan QL; Zou WY; Song LH; Wei W
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines.
    Ko D; Raaphorst GP; Feeley MM; Danjoux CE; Maroun JA; Evans WK
    Anticancer Res; 1991; 11(1):235-9. PubMed ID: 1850216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracranial transplantation of human hematopoietic cell lines in nude mice: a preclinical screening model for cytostatic drugs.
    Engert A; Kirchner HH; Schaadt M; Diehl V
    Anticancer Res; 1987; 7(1):49-53. PubMed ID: 3566183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alkylphosphonium salts as a new class of antitumor agents.
    Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
    Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antineoplastons: biochemical defense against cancer.
    Burzynski SR
    Physiol Chem Phys; 1976; 8(3):275-9. PubMed ID: 1013179
    [No Abstract]   [Full Text] [Related]  

  • 32. Clonogenic assays for the chemotherapeutic sensitivity of human tumours.
    Lancet; 1982 Apr; 1(8275):780-1. PubMed ID: 6121231
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive assays on individual human cancers to select active drug treatment.
    Knock FE; Galt RM; Oester YT; Sylvester R
    Indian J Med Res; 1978 Jul; 68():107-15. PubMed ID: 700836
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxygen consumption by acrylamide polymerization: a method for rapid screening of anticancer agents.
    Tapper D; Johnson R; Folkman J
    J Surg Oncol; 1975; 7(6):513-20. PubMed ID: 1186268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chemotherapeutic agents on the lipids of transplantable tumours.
    HOLCZINGER L
    Acta Unio Int Contra Cancrum; 1960; 16():662-4. PubMed ID: 14402563
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of inhibition of human tumor tissue by cancer chemotherapeutic drugs with an in vitro test.
    DIPAOLO JA; DOWD JE
    J Natl Cancer Inst; 1961 Oct; 27():807-15. PubMed ID: 13886539
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro assessment of chemotherapeutic activity in cancer.
    DIPAOLO JA; DOWD JE
    N Y State J Med; 1962 Jul; 62():2127-33. PubMed ID: 13886540
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory effect of sucrose ester of lauric acid on the growth of Escherichia coli.
    Kato A; Arima K
    Biochem Biophys Res Commun; 1971 Feb; 42(4):596-601. PubMed ID: 5543940
    [No Abstract]   [Full Text] [Related]  

  • 39. A method for the evaluation of chemotherapeutic agents in man.
    BIERMAN HR; MARSHALL GJ; KELLY KH; ALEXANDER MJ
    Cancer; 1960; 13():328-33. PubMed ID: 13800590
    [No Abstract]   [Full Text] [Related]  

  • 40. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).
    Knox RJ; Friedlos F; Boland MP
    Cancer Metastasis Rev; 1993 Jun; 12(2):195-212. PubMed ID: 8375021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.